Literature DB >> 9738832

Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth.

M Desai1, T Bühler, P H Weller, M R Brown.   

Abstract

The change in resistance of Burkholderia cepacia to ceftazidime and to ciprofloxacin during the exponential phase and up to the onset of stationary phase was assessed along the growth curve in batch culture. B. cepacia was grown in planktonic culture and in a biofilm on a membrane support. Resistance increased progressively during the exponential phase, being increased by ten-fold about every four generations. Bacteria grown in a biofilm were about 15 times more resistant than equivalent planktonic-grown bacteria. The growth rate was not the key factor for the development of resistance. The growth phase and the mode of growth have a fundamental impact on the susceptibility of B. cepacia towards antimicrobial agents. Bacteria growing at the same rate may differ greatly in their resistance to antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738832     DOI: 10.1093/jac/42.2.153

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  24 in total

1.  Optimal control strategies for disinfection of bacterial populations with persister and susceptible dynamics.

Authors:  N G Cogan; Jason Brown; Kyle Darres; Katherine Petty
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 2.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 3.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

4.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.

Authors:  E Caraher; G Reynolds; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

5.  Failure of antibiotic treatment in microbial populations.

Authors:  Patrick De Leenheer; N G Cogan
Journal:  J Math Biol       Date:  2008-12-16       Impact factor: 2.259

6.  Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.

Authors:  A L Spoering; K Lewis
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

7.  Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm.

Authors:  Anil Kishen; Megha Upadya; George P Tegos; Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2010-09-22       Impact factor: 3.421

8.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

9.  Tyrosine Phosphorylation and Dephosphorylation in Burkholderia cenocepacia Affect Biofilm Formation, Growth under Nutritional Deprivation, and Pathogenicity.

Authors:  Angel Andrade; Faviola Tavares-Carreón; Maryam Khodai-Kalaki; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2015-11-20       Impact factor: 4.792

Review 10.  Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.

Authors:  Wanessa C M A de Melo; Pinar Avci; Milene Nóbrega de Oliveira; Asheesh Gupta; Daniela Vecchio; Magesh Sadasivam; Rakkiyappan Chandran; Ying-Ying Huang; Rui Yin; Livia R Perussi; George P Tegos; Janice R Perussi; Tianhong Dai; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-07       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.